Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:ADMS
Delisted

Adamas Pharmaceuticals Stock Price (Quote)

$8.22
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $8.22 $8.22 Friday, 27th May 2022 ADMS stock ended at $8.22. During the day the stock fluctuated 0% from a day low at $8.22 to a day high of $8.22.
90 days $8.22 $8.22
52 weeks $4.02 $8.25

Historical Adamas Pharmaceuticals prices

Date Open High Low Close Volume
Aug 25, 2016 $13.31 $13.31 $13.31 $13.31 274 000
Aug 24, 2016 $13.72 $13.72 $13.72 $13.72 391 300
Aug 23, 2016 $14.30 $14.30 $14.30 $14.30 108 200
Aug 22, 2016 $14.11 $14.11 $14.11 $14.11 201 100
Aug 19, 2016 $14.03 $14.03 $14.03 $14.03 234 000
Aug 18, 2016 $14.32 $14.32 $14.32 $14.32 169 900
Aug 17, 2016 $13.93 $13.93 $13.93 $13.93 157 000
Aug 16, 2016 $14.01 $14.01 $14.01 $14.01 138 700
Aug 15, 2016 $14.21 $14.21 $14.21 $14.21 214 800
Aug 12, 2016 $13.50 $13.50 $13.50 $13.50 158 700
Aug 11, 2016 $13.45 $13.45 $13.45 $13.45 272 800
Aug 10, 2016 $12.95 $12.95 $12.95 $12.95 230 300
Aug 09, 2016 $13.25 $13.25 $13.25 $13.25 115 000
Aug 08, 2016 $13.25 $13.25 $13.25 $13.25 233 400
Aug 05, 2016 $13.68 $13.68 $13.68 $13.68 380 600
Aug 04, 2016 $14.51 $14.51 $14.51 $14.51 83 200
Aug 03, 2016 $14.83 $14.83 $14.83 $14.83 84 100
Aug 02, 2016 $14.46 $14.46 $14.46 $14.46 169 900
Aug 01, 2016 $14.80 $14.80 $14.80 $14.80 183 100
Jul 29, 2016 $15.10 $15.10 $15.10 $15.10 781 000
Jul 28, 2016 $14.36 $14.36 $14.36 $14.36 170 200
Jul 27, 2016 $14.60 $14.60 $14.60 $14.60 200 700
Jul 26, 2016 $14.24 $14.24 $14.24 $14.24 292 700
Jul 25, 2016 $14.53 $14.53 $14.53 $14.53 363 500
Jul 22, 2016 $15.51 $15.51 $15.51 $15.51 176 800
Click to get the best stock tips daily for free!

About Adamas Pharmaceuticals

Adamas Pharmaceuticals Adamas Pharmaceuticals, Inc., a pharmaceutical company, focuses on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems. The company’s lead product candidate is the ADS-5102 that is in Phase 3 clinical development for the treatment of levodopa-induced dyskinesia, a movement disorder associated with Parkinson’s disease; and in a Phase 2 clinical study for the treatment of symptoms assoc... ADMS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT